Novo Holdings Invests Eur 86 Million In 21St.Bio, A New Bioindustrial Scale-Up Company Building On Technology Base From Novozymes
Novo Holdings Invests Eur 86 Million In 21St.Bio, A New Bioindustrial Scale-Up Company Building On Technology Base From Novozymes
12/21/21, 1:00 AM
Location
copenhagenMoney raised
€86 million
Industry
financial services
software
Novo Holdings, a leading international life sciences investor, today announced a significant investment in 21st.BIO A/S – a new Danish bioindustrial scale-up company.
Company Info
Location
copenhagen, capital region of denmark, denmark
Additional Info
The technology platform of 21st.BIO originates from selected parts of Novozymes platform, which has been developed and perfected over the past 40+ years. Established in 2020, 21st.BIO has been founded with a mission to support bioindustrial companies globally in upscaling from molecule innovation to large-scale production to be able to meet market demands and thereby advance the green transition globally.